ISIDORe (Integrated Services for Infectious Disease Outbreak Research) has announced the launch of its preparedness programme calls for proposals for free of charge access to its state-of-the-art facilities, cutting-edge services, advanced equipment and technologies. The preparedness programme includes a list of priority preparedness pathogens clustered in four calls for proposals, aligned with strategies of key leading European and international bodies which are part of the initiative’s strategic advisory board: CEPI, the European Commission, the ECDC, EFPIA, EMA, FAO, GloPID-R, HERA, WHO and WOAH.
To prevent future pandemics, and advance the development of the appropriate medical countermeasures, the ISIDORe preparedness programme four calls for proposals will support research on the pathogens with epidemic potential such as Risk-Group 4 pathogens (Ebola virus, Marburg virus, Nipah virus, Hendra virus, Lassa virus, “New world arenaviruses”, CCHF virus), respiratory pathogens (zoonotic betacoronaviruses, Influenza A, Y. Pestis, M. Tuberculosis/bovis, C. burnetii ), vector-borne pathogens (Rift valley fever virus, Zika virus, Chikungunya virus, West Nile virus, Dengue virus, Japanese encephalitis virus, Yellow fever virus, Tick-borne encephalitis virus, Plasmodium, B. burgdorferi, Leishmania), and other pathogens with epidemic potential (pathogen X, Orthopoxviruses, Non polio enteroviruses, Polio enteroviruses).
TRANSVAC2 is now also offering free vaccine R&D services as part of ISIDORe to support scientists and their research on epidemic- and pandemic-prone pathogens.
Researchers are invited to submit any proposal that requires access to at least one of the ISIDORe services, and falls under one of the sections highlighted on the calls webpage. Except for the “Risk-Group 4 pathogens” call for proposals, which has a pre-application deadline of 7 February 2022 for access to BSL4 facilities, applications will be evaluated, selected and implemented on a rolling basis as long as funding remains available. The calls are multidisciplinary and open to all scientists both from academia and private sector. Read more on application modalities on the ISIDORe website.
See Flyer here >>
ISIDORe, an interdisciplinary project coordinated by European Research Infrastructure on Highly Pathogenic Agents (ERINHA), is funded by the European Commission Horizon Europe programme through the HERA incubator call and brings together all key European life sciences research infrastructures and networks, as well as those in the social sciences. The Consortium brings together 154 partners under the umbrella of TRANSVAC, BBMRI, EATRIS, ECRIN, ELIXIR, EMBRC, EMERGEN, EUOPENSCREEN, EUROBIOIMAGING, EVA-G, INFRAFRONTIER, INFRAVEC, INSTRUCT, MIRRI, SONAR GLOBAL, VETBIONET and ERINHA.
ISIDORe has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101046133.